Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression

Area of Science:

• Molecular Virology
• Cancer Biology
• DNA Damage Response

Background:

• Epstein-Barr virus (EBV) latent antigen EBNA3C is crucial for B-cell immortalization and implicated in B-cell malignancies.
• Deregulation of H2AX, a DNA damage marker, can lead to genomic instability and tumorigenesis.

Purpose of the Study:

• To investigate the regulatory role of EBNA3C on H2AX expression and its functional consequences in EBV-infected cells.
• To elucidate the molecular mechanisms underlying the interaction between EBNA3C and H2AX.

Main Methods:

• Quantitative analysis of H2AX transcript and protein levels in EBV-infected cells.
• Co-immunoprecipitation assays to study EBNA3C-H2AX interaction.
• Luciferase reporter assays to assess promoter activity.
• Ubiquitin-proteasome pathway analysis.
• Gene knockdown experiments in lymphoblastoid cell lines (LCLs).

Main Results:

• EBNA3C significantly attenuates H2AX expression at both transcript and protein levels.
• EBNA3C directly interacts with H2AX via its N-terminal domain (residues 1-100), specifically with wild-type H2AX.
• EBNA3C promotes H2AX degradation through the ubiquitin-proteasome pathway.
• Knockdown of H2AX in LCLs results in upregulation of Bub1 oncoprotein and downregulation of p53 tumor suppressor.

Conclusions:

• EBNA3C plays a critical role in downregulating H2AX, thereby modulating the DNA damage response in EBV-infected cells.
• The interaction between EBNA3C and H2AX contributes to the oncogenic process in EBV-associated B-cell lymphomas by affecting key regulatory proteins like Bub1 and p53.